Results of treatment of primary staphylococcal enterocolitis in infants with the use of antibacterial drugs and their combination with bacteriophages: a prospective study

In infectious pathology in infants, staphylococcal infection occupies a leading place, is characterized by the rapid development of intoxication, a purulent-destructive process with the possibility of generalization of infection, affecting the course and outcome of the disease.

The aim of the study was to study the results of treatment of primary staphylococcal enterocolitis, in infants, with the use of antibacterial drugs and their combination with bacteriophages.

Research methods. The frequency of elimination of staphylococcus, the duration of the main symptoms (fever, diarrhea, toxicosis with exicosis) as a result of treatment of primary staphylococcal enterocolitis (confirmed by laboratory) were analyzed in children aged from 1 to 12 months who received inpatient antibacterial drugs (nifuroxazide, azithromycin) or their combination with bacteriophages (staphylococcal, pyobacteriophage). The data accounting period is from January 2017 to December 2020.

The results of the study. The results of treatment of staphylococcal enterocolitis were studied in 4 groups: monotherapy with nifuroxazide (n = 39) or azithromycin (n = 40), a combination of nifroxazide+staphylococcal bacteriophage (n = 41) or azithromycin + piobacteriphage (n = 38). The groups were comparable by gender, age, and clinical manifestations of the disease. Elimination of staphylococcus on the 10th—12th day. treatment with monotherapy with antibacterial drugs was achieved in 31—35%, with their combination with bacteriophages — in 51—64% of patients in each combination (df = 3, p < 0.05). Against the background of combined therapy, the symptoms of the disease (diarrhea, vomiting) were stopped 1.2 times faster; the number of patients with lactase deficiency and intestinal dysbiosis decreased by 1.7—2 times, with monotherapy with antibacterial drugs-by 1.3—1.4 times (df = 3, p < 0.05).

Conclusion. Treatment of primary staphylococcal enterocolitis in children, including antibacterial drugs and bacteriophages, is more effective than monotherapy with antibacterial drugs.

1. Anganova E.V. Antibiotic resistance of conditionally pathogenic enterobacteria isolated in children with acute intestinal infections. Sibirskij med. zhurnal=Siberian Medical Journal. 2012; 7: 98—99. (In Russ.)

2. Mikhailova L.V. Drug resistance of conditionally pathogenic enterobacteria of pathogens of acute intestinal infections. Al'manah mirovoj nauki = Almanac of World Science. 2016; 8:21—22. (In Russ.)

3. Regine M. Fortunov Evaluation and treatment of community-acquirell Staphylococus aureus infections in term and late-preterm previously healtry neonates. Pediatrics. 2007; 120: 937—945.

4. Nikolaeva I.V., Anokhin V.A., Aikutdinova I.A. Characteristics of intestinal microflora in healthy infants in Kazan. Ross vestn. neonatal. i pediatrii = Ross. westn. neonatol and pediatrics. 2009; 2:30—34. (In Russ.)

5. Nikolaeva I.V., Anokhin V.A. Staphylococcal infections in pediatrics. Prakticheskaya medicina=Practical medicine. 2010; 40 (1):24—27. (In Russ.)

6. Timofeeva G.I., Antipova L.A. Infectious diseases in children of the first year of life. M.: Medicine; 1985 (In Russ.)

7. Mankevich R. N., Matush L. I., Lagir G. M. Campylobacteriosis. Staphylococcal enterocolitis. Intestinal dysbiosis in children. Minsk: BSMU;2020 (In Russ.)

8. Novokshonov A.A., Mazankova L.N., Uchaykin V.F. Clinical recommendations for the diagnosis and treatment of acute intestinal infections in children, depending on the type of diarrhea. Lechenie i Profilaktika=Treatment and Prevention. 2013; 8(4):62—73 (In Russ.)

9. Ruzhentseva T.A., Ploskireva A.A., Milutina L.N. Gorelov A.V. Features of the use of antibacterial therapy in children with acute intestinal infections. Medicinskij Sovet=Medical advice. 2016; 1:98— 101. (In Russ.)

10. Mazankova L.N., Korsunsky A.A., Prodeus A.P., Ardatskaya M.D., Perlovskaya S.G. Improving the tactics of biocenosis-sparing therapy when using antibiotics in children with acute intestinal infections. Detskie Infekcii=Children's Infections. 2017; 16(3):41—49. (In Russ.) https://doi.org/10.22627/2072-8107-2017-16-3-41-49

11. Bykov A.S., Bykov S.A. Bacteriophages and their clinical purpose. Farmateka=Pharmateca. 2011; 5: 67—72. (In Russ.)

12. Bekhtereva M.K., Ivanova V.V. The place of bacteriophages in the treatment of infectious diseases of the gastrointestinal tract. Pediatriya= Pediatrics. 2014; 2: 36—40. (In Russ.)

13. Bielaszewska M., Idelevich E.A., Zbang W. et al. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli 0104:H4 strain. Antimicrob Agents Chemother. 2012; 56(6): 3277—3282.

14. Shriner E.V., Denisov M.Yu. Lactase deficiency in children: the current state of the problem. Bulletin of the Novosibirsk State University. Biologiya, klinicheskaya medicina=Biology, clinical medicine. 2009; 7(4):154—162. (In Russ.)

15. Bruzzese E., Giannattasio A., Guarino A. Antibiotic treatment of acute gastroenteritis in children Version 1. Res. 2018; 7: 193.

16. Zakharova I.N. Esinov A.V., Doronina E.A., Loverdo R.G., Dmitrieva Yu.A. Pediatrician's tactics in the treatment of acute gastroenteritis in children what's new. Voprosy sovremennoj pedi-atrii=Questions of modern pediatrics. 2013; 17:4:120—125. (In Russ.)

17. Ursova N.I. Intestinal dysbiosis in childhood: innovations in diagnosis, correction and prevention. M.: Publishing house: MONIKI named after M. F. Vladimirsky, 2013; ISBN: 978-5-915791-10-6. (In Russ.)

18. Zakharenko S.M. therapy of intestinal infections in Russia: rational or empirical. Zhurn. Infektologii=Journal of Infectology. 2011; 3(2): 81—96. (In Russ.)

19. Ploskireva A.A. Tactics of a practical doctor in acute intestinal infections in children. Farmateka=Pharmateca. 2014; 11:20—27. (In Russ.)

20. Pechkurov D.V., Bochkareva N.M., Gasilina E.S. Principles of therapy of acute intestinal infections in children at the present stage. Far-mateka= Pharmateca. 2017; 11:57—62. (In Russ.)

21. Khokhlova N.I., Krasnova E.I., Provorova V.V., Vasyunin A.V. OKI of viral and bacterial etiology in children: modern possibilities of diagnosis and therapy, the role of metabiotics. Lechashchij Vrach=The Attending Physician. 2018; 6:33—39. (In Russ.).

22. Guarino A., Albano F., Ashkenazi S., Gendrel D., Hoekstra J. H., Shamir R., Szajewska H. European Society for Paediatric Gastroenterology, Hepatology and Nutrition/European Society for Paediatric Infectious Diseases Evidence-based Guidelines for the Management of Acute Gastroenteritis in Children in Europe. J. Pediat Gastroenterol Nutr. 2008; 46(2):81—122.

23. Gorelov V.A., Milyutin L.N., Usenko D.V. Treatment of acute intestinal infections in children: a Handbook for physicians. Moscow: Central research Institute of Epidemiology, 2003. (In Russ.).

24. Geppe N.A., Gorelov A.V., Dronov I. A. Problems of antibacterial therapy for intestinal infections in children. Medicinskij sovet =Medi-cal advice. 2011; 5: 22—26. (In Russ.).

25. Gorelov A.V., Usenko D. V., Kadzhieva E. P., Ardatskaya M. D. Evaluation of the clinical efficacy of enterofuril in the complex therapy of acute intestinal infections in children and its effect on intestinal microbiocenosis. Infectious Diseases. 2006; 4:79—83. (In Russ.).

26. Kadzhieva E.N., Usenko D.V., Gorelov A.V., Ardatskaya M.D. Modern nitrofurans in the treatment of intestinal infections in children. Farmateka=Pharmateka. 2007; 13:79—82. (In Russ.).

27. Tavares L.C., Chiste J.J., Santos M.G., Penna T.C. Synthesis and biological activity of nifuroxazide and analogs. II. Boll Chim Farm. 1999, Sep; 138(8):432—436.

28. Diniz-Santos Daniel R., Silva Luciana R., Silva Nanci. Antibiotics for the Empirical Treatment of Acute Infectious Diarrhea in Children. The Brazilian Journal of Infectious Diseases. 2006; 10(3):217—227.

29. Milutina L.N., Vorotyntseva N.V. Modern strategy and tactics of etiotropic therapy of acute intestinal infections in children. Antibiotiki i himioterapiya=Antibiotics and chemotherapy, 1993; 38(1):46— 48. (In Russ.).

30. Katter E., Sulakvelidze A. Bacteriophages: biology and practical application. Moscow: Nauchny mir, 2012. (In Russ.).

31. Topchiy N.V., Toporkov A.S. Bacteriophages in the treatment of acute intestinal infections. Medicinskij sovet=Medical Council. 2015; 8:74—81. (In Russ.).

32. Drucker V.V., Gorshkova A.S. Bacteriophages and their functioning in biofilms. Izv. Irkut. state University. Ser. Biology. Ecology, 2012; 5(3):8—16. (In Russ.).

33. Miroshnikov K.A., Chertkov O.V., Nazarov P.A., Mesyanzhinov V.V. Peptidoglycanizing enzymes of bacteriophages are promising antibacterial agents. Uspekhi Biologicheskoj Himii=Advances in biological chemistry. 2006; 46:65—98. (In Russ.).